LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
11,038,886
Share change
-1,364,627
Total reported value
$3,877,403
Price per share
$0.35
Number of holders
29
Value change
-$595,945
Number of buys
7
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q2 2022

As of 30 Jun 2022, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,038,886 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, HARBOR CAPITAL ADVISORS, INC., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and PRUDENTIAL FINANCIAL INC. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.